Core Viewpoint - NeuroOne Medical Technologies Corporation has announced a public offering of 16,000,000 shares of common stock at a price of 8,000,000 in gross proceeds for general working capital purposes [1][3]. Group 1: Offering Details - The offering consists entirely of shares sold by the Company, with an additional 45-day option for the underwriter to purchase up to 2,400,000 additional shares at the public offering price [2]. - The expected gross proceeds from the offering, before deductions, are $8,000,000, with the closing anticipated on or about April 7, 2025, subject to customary conditions [3]. Group 2: Regulatory Information - The shares will be issued under a shelf registration statement on Form S-3, which was declared effective by the SEC on August 16, 2024 [4]. - A preliminary prospectus supplement and accompanying prospectus have been filed with the SEC and are available on their website [4]. Group 3: Contact Information - For further inquiries, contact information for the MZ Group is provided, including a phone number and email address [7][8].
NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock